Skip to search.
 FTSE 100 Up 0.08%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
1.75 Up 0.13(8.02%) 27 May 21:00
Prev Close:1.62
Open:1.62
Bid:1.60 x 15000
Ask:1.80 x 300
1y Target Est:3.00
Beta:1.45465
Earnings Date:3 Aug - 8 Aug (Est.)
Day's Range:1.62 - 1.76
52wk Range:1.30 - 5.12
Volume:2,390,964
Avg Vol (3m):2,044,110
Market Cap:425.33m
P/E (ttm):N/A
EPS (ttm):-0.44
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ARNA at this time.

Comparison

Symbol% ChgMkt Cap
ARNAUp 8.02%425.33m
OREXUp 1.68%60.69m
GSKDown 0.79%103.84b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.34
Quarterly EPS Est (Jun-16) :-0.10
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.24

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors to address unmet medical needs in the United States and South Korea. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback